Non-dopaminergic treatments in development for Parkinson's disease

Summary Non-dopaminergic treatments are increasingly being recognised as part of the therapeutic armamentarium for Parkinson's disease (PD). Clinical and pathological studies have shown that the disease extends beyond the substantia nigra pars compacta and involves various non-dopaminergic neur...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Lancet neurology 2008-10, Vol.7 (10), p.927-938
Hauptverfasser:	Fox, Susan H, MRCP, Brotchie, Jonathan M, PhD, Lang, Anthony E, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiparkinson Agents - adverse effects Antiparkinson Agents - therapeutic use Autonomic Nervous System Diseases - etiology Cognition Disorders - etiology Humans Mental Disorders - etiology Models, Biological Mood Disorders - etiology Neurology Parkinson Disease - drug therapy Parkinson Disease - pathology Parkinson Disease - physiopathology Parkinson's disease
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!